Carbylan Therap Cmn (CBYL) 0.50 $CBYL Carbylan
Post# of 273332
Posted On: 09/25/2016 1:13:02 PM
Carbylan Therap Cmn (CBYL) 0.50 $CBYL
Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan Therapeutics, Inc.; Encourages Investors to Contact the Firm
PR Newswire - Fri Sep 23, 6:53AM CDT
Shareholder rights law firm Johnson & Weaver, LLP's investigation into whether certain officers and directors of Carbylan Therapeutics, Inc. (NASDAQ: CBYL) violated federal securities laws continues. Carbylan is a specialty pharmaceutical company, focusing on the development and commercialization of novel and proprietary combination therapies.
CBYL: 0.50 (+0.01)
Research Report Initiation on Generic Drugs Makers Stocks -- Ironwood Pharma, The Medicines, Carbylan Therapeutics, and Pacira Pharma
PR Newswire - Wed Aug 24, 7:00AM CDT
The global Generic Drugs market is forecasted to grow at a CAGR of 10.53% over the period of 2016 to 2020, according to the 'Global Generic Drugs Market 2016-2020' report released in June 2016. Today, Stock-Callers.com assesses the following companies stocks to see if they are poised for higher returns: Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), The Medicines Co. (NASDAQ: MDCO), Carbylan Therapeutics Inc. (NASDAQ: CBYL), and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX). Learn more about these stocks by downloading their free report at: http://stock-callers.com/registration
IRWD: 15.72 (-0.15), MDCO: 40.45 (-1.05), CBYL: 0.50 (+0.01), PCRX: 36.86 (-0.66)
Why Investors Have This Drug Makers' Stocks on Their Radar? - Carbylan Therapeutics, Catalent Inc., Medicines Co., and Diplomat Pharmacy
PR Newswire - Mon Jun 06, 7:00AM CDT
The Generic Drugs space is an attractive yet very competitive industry. In today's lineup, ActiveWallSt.com have these companies: Carbylan Therapeutics Inc. (NASDAQ: CBYL), Catalent Inc. (NYSE: CTLT), The Medicines Co. (NASDAQ: MDCO), and Diplomat Pharmacy Inc. (NYSE: DPLO). Learn more about these stocks and receive your complimentary trade alerts at:
MDCO: 40.45 (-1.05), DPLO: 29.21 (-0.32), CTLT: 26.70 (+0.07), CBYL: 0.50 (+0.01)
Robbins Arroyo LLP is Investigating the Officers and Directors of Carbylan Therapeutics, Inc. (CBYL) on Behalf of Shareholders
BusinessWire - Wed Jun 01, 12:14PM CDT
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Carbylan Therapeutics, Inc. (NASDAQGM: CBYL) violated federal securities laws in connection with its initial public offering ("IPO"
. Carbylan Therapeutics is a specialty pharmaceutical company that develops and commercializes novel and proprietary combination therapies.
CBYL: 0.50 (+0.01)
Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan Therapeutics, Inc.; Encourages Investors to Contact the Firm
PR Newswire - Fri Sep 23, 6:53AM CDT
Shareholder rights law firm Johnson & Weaver, LLP's investigation into whether certain officers and directors of Carbylan Therapeutics, Inc. (NASDAQ: CBYL) violated federal securities laws continues. Carbylan is a specialty pharmaceutical company, focusing on the development and commercialization of novel and proprietary combination therapies.
CBYL: 0.50 (+0.01)
Research Report Initiation on Generic Drugs Makers Stocks -- Ironwood Pharma, The Medicines, Carbylan Therapeutics, and Pacira Pharma
PR Newswire - Wed Aug 24, 7:00AM CDT
The global Generic Drugs market is forecasted to grow at a CAGR of 10.53% over the period of 2016 to 2020, according to the 'Global Generic Drugs Market 2016-2020' report released in June 2016. Today, Stock-Callers.com assesses the following companies stocks to see if they are poised for higher returns: Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), The Medicines Co. (NASDAQ: MDCO), Carbylan Therapeutics Inc. (NASDAQ: CBYL), and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX). Learn more about these stocks by downloading their free report at: http://stock-callers.com/registration
IRWD: 15.72 (-0.15), MDCO: 40.45 (-1.05), CBYL: 0.50 (+0.01), PCRX: 36.86 (-0.66)
Why Investors Have This Drug Makers' Stocks on Their Radar? - Carbylan Therapeutics, Catalent Inc., Medicines Co., and Diplomat Pharmacy
PR Newswire - Mon Jun 06, 7:00AM CDT
The Generic Drugs space is an attractive yet very competitive industry. In today's lineup, ActiveWallSt.com have these companies: Carbylan Therapeutics Inc. (NASDAQ: CBYL), Catalent Inc. (NYSE: CTLT), The Medicines Co. (NASDAQ: MDCO), and Diplomat Pharmacy Inc. (NYSE: DPLO). Learn more about these stocks and receive your complimentary trade alerts at:
MDCO: 40.45 (-1.05), DPLO: 29.21 (-0.32), CTLT: 26.70 (+0.07), CBYL: 0.50 (+0.01)
Robbins Arroyo LLP is Investigating the Officers and Directors of Carbylan Therapeutics, Inc. (CBYL) on Behalf of Shareholders
BusinessWire - Wed Jun 01, 12:14PM CDT
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Carbylan Therapeutics, Inc. (NASDAQGM: CBYL) violated federal securities laws in connection with its initial public offering ("IPO"
. Carbylan Therapeutics is a specialty pharmaceutical company that develops and commercializes novel and proprietary combination therapies. CBYL: 0.50 (+0.01)
(0)
(0)